• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR

PARADIGM BIOPHARMACEUTICALS LIMITED.. - Charts / Financials

5.00% ! 28.5¢
Market Cap $110.9M  !

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight arrow Created with Sketch.

PAR - close to a cure for osteoarthritis?
refresh Created with Sketch. REFRESH
Day
Open 30.0¢   Day High 30.5¢   Day Low 28.5¢
Daily Volume 650646
Bids   Sellers
Number Price Volume   Number Price Volume
5 28.5¢ 75761   5 30.0¢ 66949

Directors & Senior Management

Mr. Paul Rennie Executive Chairman of the Board, Managing Director
Ms. Abby Macnish Niven Chief Financial Officer, Company Secretary
Mr. Matthew James Fry Non-Executive Director
Mr. Amos Meltzer Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.5¢
Change
-0.015(5.00%)
Mkt cap ! $110.9M
Open High Low Value Volume
30.0¢ 30.5¢ 28.5¢ $190.8K 650.6K

Buyers (Bids)

No. Vol. Price($)
5 75761 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 66949 5
View Market Depth
Last trade - 16.10pm 06/06/2025 (20 minute delay) ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.